Bone drug fails to launch in ACL study
NCT ID NCT05204836
First seen Jan 05, 2026 · Last updated Jun 11, 2026 · Updated 26 times
Summary
This study tested whether a single injection of zoledronic acid could prevent bone and joint damage after an ACL tear. Only 4 people took part before the study was stopped early. The goal was to see if the drug could slow down changes that lead to arthritis.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ANTERIOR CRUCIATE LIGAMENT TEAR are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
University of Calgary
Calgary, Alberta, T2N 1N4, Canada
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.